Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal bevacizumab versus triamcinolone versus placebo for acute nonarteritic anterior ischemic optic neuropathy
IRCT1138901221180N13Phase 2Completed
- Sponsor
- Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab and triamcinolone in non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences. Started Nov 2009; status: completed.
02
Drugs
bevacizumabtriamcinolone
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on IRCT1138901221180N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT1138901221180N13.